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Dermatitis herpetiformis {DH} is associated with a markedly 
increased frequency of the HLA class II antigens DR3 and 
DQw2. T o investigate a possible role ofHLA-DP (or closely 
associated genes) in the pathogenesis of DH as well as to 
confirm the previously described alterations of HLA-DR3 
and HLA-DQw2 antigen frequency, we have typed 43 pa-
tients with DH for HLA-DP, HLA-DQ, and HLA-DR anti -
gens. All patients with DH had typical clinical and histologic 
features, as well as granular deposits of IgA at the dermal-
epidermal junction by direct immunofluorescence. H LA-
DR3 was expressed in 41 of 43 {95%} DH patients, whereas 
HLA-DQw2 was expressed in all 43 {IOO%}. The overall 
distribution of HLA-DP antigens in patients with DH was 
significantly different from that seen in all controls and in 
HLA-DR3 and HLA-DQw2 controls (p<0.02). Examina-
tion of the frequency of individual DP antigens revealed that 
HLA-DPwl was increased {42% of patients with DH vs II % 
of all controls and 26% of DR3 positive controls}, but this 
D ermatitis herpetiformis (DH) is a chronic blistering disease with charcteristic granular IgA deposits at the dermal-epidermal juncton (DE]), an associated, most often asymptomatic, gluten sensitive enterop-athy (GSE). and a strong association with specific 
HLA antigens [1]. InitiaUy. the HLA class I antigen B8 was found 
to occur in 58-79% of patientS with DH as compared with about 
20% of ethnically matched controls 12]. This HLA association was 
further strengthened in subsequent studies by the more rigorous 
defmition of patient groups [3}. Eighry to 90% ofDH patients with 
granular IgA deposits at the DE] were found to be HLA-BS, 
whereas thc frequency of HLA-BB in patients with clinically identi-
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Abbreviations: 
ELISA: enzyme-linked immunosorbcnt assay 
DE]: dermal -epidermal junction 
DH : dermatitis herpetiformis 
GSE: ghm:n sensitive emeropathy 
MHC: major histocompatibility complex 
RFLP: restriction fragment lengtb polymorph isms 
increase was not statistically greater than that expected due to 
the disequilibrium linkage of DPwl with DR3/DQw2. Pa-
tients with 0 H I however I did have a statistically significant 
decreased frequency of DPw2 {14% of patients vs 31 % of all 
conrrols and 41 % ofDR3 positive controls} (Po <0.05) . Stud-
ies of three informative families demonstrated tbat the DPw2 
genes of the DH patients were not present on the haplotype 
thought to carry a DH susceptibility gene (HLA-AI, 
HLA-B8, HLA-DR3, HLA-DQw2). A role ofHLA-DP re-
gion genes in the pathogenesis of DH is further suggested by 
the observation that HLA-DPwl was expressed in 82% {9 of 
II} of DH patients with IgA antibodies against dietary anti-
gens as compared with only 33% {4 ofl2} of patients without 
IgA antibodies. HLA-DP genes or genes closely linked to 
them may be important in DH either as markers of the disease 
haplotype or by direct involvement in its patbogenesis. J 
[" vest Dertnatol93 :501-505, 1989 
cal disease bue linear IgA deposits (linear IgA dermatosis) was not 
increased relative to controls 141. The importance of the major his-
tocompatibi liry complex (MHC) in the pathogenesis of DH has 
been further documented by the finding by a number of investiga-
tors of an even stronger association between DH and the class n 
HLA antigen DR3 (90-95% of DH patients) 151. HLA-BB and 
HLA-DR3 are alleles that arc known to be in linkage disequilibrium 
in that thC'y occur togethcr more frequently than would be predicted 
by a random distribution of each allele in the population. This 
suggests that the increased frequency of the HLA-B8 allele is sec-
ondary [Q the strong association of HLA-DR3 and DH. Together 
these data ha,!e led to the hypothesis that the class n MHC region 
may be of more importance in the pathogenesis ofDH than the class 
) (HLA-A, -B, -C antigens) region. 
The importance of the HLA class n region in DH was further 
documented by Park and co-workers [6) who reported that 93% of 
patients with DH expressed the HLA antigen T e24. T e24 was 
subsequently found to be similar to HLA-DQw2. an aUele of a 
second HLA class II locus HLA-DQ [7J. Recently, Sachs and co-
workers ISJ further characterized the HLA class 11 phenorype of28 
pa{lcnts with DH. Eighry-eight percent of their patients with DH 
were found to express HLA-,DR3 and in addition 18 of 19 (95%) 
patients typed for HLA-DQ were found to express DQw2. 
A third locus of expressed HlA class II genes, now designated 
HLA-DP. has been identified by primed lymphocyte typing and 
mapped centrome.ric to the HLA-DQ locus in the class 11 region of 
chromosome 6 [9.10]. Because of the apparent importance of class 11 
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genes in influencing dis.ease susceptibility, the role of HLA-DP in 
disease has begun co be: investigated [11 - 16J. Srudies of patients 
with multiple sclerosis have suggested that HLA-OP may playa role 
in the genetic susceptibil ity to muJtiple sclerosis either alone or in 
a synergistic manner with HLA-DR antigens fI3,14J, whereas rwo 
independenr studies have documented a significant association 
between pauciarcicular juvenile -rheumatoid arthritis and HLA-
DPw2 not secondary to linkage disequilibrium with other HLA 
class II alleles 115, 16J. 
The HLA-OP phenotypes of patients with DH have not been 
previously investigated, however. recent studies of the immuno-
genetics of ordinary GSE (without DH) suggest that the HLA-DP 
region may play an important role in the pathogenesis of ordinary 
GSE. H owell and co-workers (17,18] have recenrly reported an 
increased frequency of specific restrictiou fragment length poly-
morphisms (RFLP) of the HLA-OP region in patients with ordinary 
GSE when compared with nOnn;l1 H LA-DR3 controls. They have 
characterized ,hese as RFLP of the HLA-DP" and fJ genes [17, 18J. 
The association of OH with GSE, the similar HLA-OQ and HLA-
DR phenotypes of patients with DH and those with ordinary GSE, 
and the data of HowelJ and co-workers suggests that the HLA-OP 
region may play an important role in the pathogenesis of DH. To 
furrher characterize the association ofDH and the three major class 
1I HLA antigens we have performed HLA-DP, HLA-DQ, and 
HLA-DR typing on patients with DH, family members, and 
healthy controls. In addition, in the patients with DH we have 
measured the presence ofJgA antibodies against dietary antigens to 
detennine if there is an association between the mucosal immune 
response to dietary antigens and HLA phenotype. 
SUBJECTS AND METHODS 
Subjects Forty-three white patients with dermatitis herpetiformis 
were HLA typed as described below for HLA-A, HLA-B, HLA-DP, 
HLA-DQ , and HLA-DR. The diagnosis of DH was established by 
the presence of typical cl inical and hisrologic features and the pres-
ence of granular IgA deposits at the DE] of normal appearing skin 
usillg direct immunofluorescence. 
Two hundred nonnal blood donors were also HLA typed as 
controls. 
Methods 
HUI T),pj"g HLA-A, HLA-B. HLA-DR, and HLA-DQ specifici-
ties were typed by complement-dependent cytotoxicity on nylon 
wool B cell-enriched mononuclear lymphocytes [19 - 21]. 
HLA-DP alleles were determined by primed lymphocyte ryping 
as previously described [22]. Primed lymphocyte reagents specific 
for HLA-OPwl -S were used for ryping 122.23j. In addi tion. two 
previously described HLA-DPw2 specific cytoto"xic T cell clones, 
8.4 and 8.9. were included as responder ceUs [241. Primed cells were 
thawed and plated in triplicate in flat-bottom microtitcr plates, at 
0.2 X 10s per well and stimulator peripheral blood mononuclear 
cells added (I X 10' cells per wel l) in a final volume of 200 1'1 of 
RPMI-1640 with 10% hea t inactivated plasma for 48 h. pulsed with 
1 ,£lei of 3H-thymidine per well. incubated an additional 18 h. 
harvested on a fiberglass mat harveste r. and P emissions counted. 
The results of each primed lymphocyte ryping reagent in the panel 
were analyzed by both arithmetic and geometric cluster analysis 
and the assignment of HLA-DP antigens was made as pre:viously 
described [22]. T o ascertain the HLA haplotypes on 3 patients with 
DH , HLA ryping was also performed on materna.! and paternal cells 
of these three OH patients. 
AsstJys for IgA Antibodies Agajtlsr Dietary Antigens Enzyme-linked 
immunosorbcnc assays (ELISA) were performed on sera from 23 
unselected OH patients for the presence of IgA antibodies against 
rhe dietary antigens gliadin, bovine p-Iactoglobulin. bovine gamma 
globulin, and bovine casein as previously described [25]. Immuno-
globin A antidietary antibodies were considered to be present if the 
amount of speci fic IgA antibody detected by ELISA exceeded the 
upper 95% confidence level for 16 non-HLA-selected normal sub-
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jects as previously described \25]. Results were assessed without 
knowledge of the HLA rype of patients. 
Statistical Analysis Odds ratio (relative risk) and Fisher's 2-tailed 
exact te~t wer~ applied to the data. Because the pu~se of the study 
was [0 lnvesngate the HLA-DP phenorye of panenrs with DH. 
corrected p values were calculated only for the freq uency of HLA-
D P alleles by multiplying by the rotal number ofHLA-DP antigens 
ryped (BonferonID correction). Chi-square analysis was applied 
to dctermine overall differences between control and patient pop-
ulations. 
RESULTS 
HLA Typing Illitial HLA typing was performed on our paticnts 
with DH to determine the frequency of HLA-A, HLA-B, HLA-
OQ. and HLA~DR antigens. As previously described elevations in 
,he frequency of the antigens HLA-AI (74%), HLA-B8 (88%), and 
HLA-DR3 (95%) were present in our DH patients (Table I). HLA-
DQw2 was present in 100% of the 43 pouients with DH as com-
pared with only 40% of conrrol subjects (relative risk = infinity). 
HLA-DP ryping was performed using primed lymphocyte typing 
with [he same reagents and techniques used to originally define the 
DP antigens (T able J). T he overall distribution of all DP antigens in 
the patients with OH was significantly di1ferent (p<0.0002) from 
the DP distribution among the normal , non-HLA selected controls. 
Evaluation of the frequency of occurrence of individual OP antigens 
also revealed significant differences berween patients with DH and 
normal controls. Patients wi th DH had a striking increase in the 
frequency ofDPw t , as well as an apparen[ increase in OPw3 and a 
decrease in DPw2 (Table I). 
The nonrandom distribution of DP phenotypes in these D H pa-
tients could be rhe result of a gene closely linked to the DP-region, 
whjch may playa role in the determination of susce:ptibil iry to OH 
or secondary to a linkage djsequilibrium of OP al lele(s) to DR3 and 
or DQw2. T o distinguish these: possibilities, we compared the 
freq uency of OP antigens among DH patients with that of normal 
subjects expressing the relevant DR3 or DQw2 alleles. 
The overall distribution of all DP antigens in DH patients was 
significantly different (p = 0.02) from the distribution of OP anti-
gens in DR3-positive normal subjects (T able II) and DQw2 posi tive 
individuals (p = 0.02) (Table III). From these findings , we suggesr 
that the overall noncandom distribution of DP phenotype observed 
Table I. HLA Class II Antigen Frequency in Patients with DH 
and Normal Subjects 
Antig~n Normal Subjects DH Relative Risk 
DP (n ~ 200) (n - 43) 
DPwi 21( 11 )' 18(42) 6.1" 
DPw2 61(3 1) 6(1 4) 0.4 
DPw3 34( 17) 14(33) 2.4 
DPw4 137(69) 25(58) 0.6 
D PwS 10(5) 1(2) 0.5 
DQ (n ~ 106) (n = 43) 
DQwl 67(63) 20(47) 0.4 
DQw2 42(40) 43(100) Infmity 
DQw3 52(49) 10(23) 0.3 
DR (n = 200) (n ~ 43) 
DR I 42(2 '1) 0(0) 0.0 
DR2 64(32) 7(J6) 0.4 
DR3 46(23) 41(95) 68.6 
DR4 67(34) 7(16) 0.4 
DRS 32(16) 3(7) 0.4 
DRw6 28(14) 17(30) 4.0 
DR7 41 (2 1) 8(19) 0.9 
• Num~t po5irive- (%). 
• Fishe-r 's corn:cte-d p val ut - 0.00005. 
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Table n. HLA-DP Antigen Frequency in DR3-Positive DH 
Patients and DR3-Positive Controls 
Normal Subjects DH 
Antigen (n ~ 46) (n ~ 41) Rdacive Risk 
DPwl 12(26)" 18(44) 2.2 
DPw2 19(41) 6( 15) O.2~ 
DPw3 6( 13) 13(32) 3.1 
DPw4 31(67) 24(59) 0.7 
DPw5 2(4) 1(1) 0.6 
• Number posirive (%). 
~ Fisher', COITttu:d p v~luC' - 0.05. 
in our patients with DH is nO[ primarily due to linkage disequilib-
rium berween DP and DQ or DP and DR. 
Having determined tbat tbe overall distribution of DP alleles is 
altered in DH, ah erations in individual allele freq uency were exam-
ined to determine if the markedly increased frequency of DPw1 
observed in patients with DH (T able I, Pc = 0.00005) was due to 
tite known linkage disequilibrium between DR3 and DPwl j12J. 
When the HLA-DP antigen frequency is compared between DR3-
positive DH patients and DR3-positive nonnal controls, DPwl 
frequency continues to be increased (44% vs 26%), as it is when 
DQw2 patients and controls are compared (42% vs 15%). These 
resules, however, do not reach statistical significance when cor-
rected for the number of alleles examined (Tables II and HI). These 
data suggest that DPw1 may not be elevated to a much greater 
extent than can be accounted for by linkage disequilibrium ofDPwl 
and DR3 (and DQw2). 
T he DPw2 allel(' was decreased in frequency in parients with DH 
(Table I) and was statistically significant in the more informative 
comparisons of pariems with DR3-positive and DQw2-positive 
controls (Po = 0.05) (T ables II and 1lI). 
T his finding is consistent wirh eirher a negative linkage disequi-
librium in which the putative DH disease gene is present on the 
subset of DR3/ DQw2 haplorypes rhat do not have DPw2; or a 
protective effect of DPw2 (or some gene closely linked to it). T hese 
hypotheses differ wirh respect to the expected distribution of DPw2 
alleles between parient haplotypes wirh DR3 and those wirhour 
DR3. If the alteration results from a negative linkage disequilib-
ri um, then DPw2 should be less frequent only on the haplotype 
carrying the "disease gene." which most often would be the one 
encoding DR3 and DQw2. 
This distribution was amenable to study in three families (Table 
IV). In all th ree cases the HLA-DPw2 antigen was not present on 
the haplotype thought to encode the disease gene (HLA-A 1, 
HLA-B8. HLA-DR3. HLA-DQw2) suggesting a negative linkage 
disequilibrium between OPw2 and rhe OH disease gene. 
lm.munoglobin A Antibodies to Dietary Antigens and HLA 
Type Sera from 23 of the 43 paticnrs with DH were analyzed for 
IgA antibodies againsr the dietary antigens gliadin, bovine p-lacto-
g,lobulin. bovine gamma globulin. and bovine casein using ELISA 
[25]. Eleven of23 (48%) patients had IgA antibodies against one or 
more of the dietary antigens (T able V). The IgA antibodies were 
Table lli. HLA-DP Antigen Frequency in DQw2-Positive DH 
Patients and DQw2-Posi ti ve Controls 
Antigen 
DPwl 
DPw2 
DPw3 
DPw4 
DPw5 
Norma.! Subjects 
(n - 33) 
5(15}-
14(42) 
6(18) 
22(67) 
1(3) 
• NUlllber positivt" (%). 
~ Fisher', correcred p val ue - 0 .05. 
DH 
(n - 43) 
18(42) 
6(14) 
14(33) 
24(59) 
1(2) 
R elative Risk. 
4.0 
O.2~ 
2.2 
0.7 
0.8 
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Tabl. rv. Family Studies of Pat ients with 
Dermatitis H erpetifonnis 
Family Relation Haplotype DPw DQw DR B A 
Paden! , 2 3 4 44 2 
d" 4 2 3 8 I 
Father , 2 3 4 44 2 
b 4 3/ - ' 8 44/ - ' 3 
Mother c 3 3 4 35 3 
d 4 2 3 8 I 
2 Patient , 2 2/ - ' 7 14 II 
d" 2 3 8 I 
Father , 2 2/ - ' 7 14 II 
b 3 2/ - ' 2 27 2 
Mother , 4 I 2 62 2 
d 2 3 8 I 
3 llatiem b 2 2/-' 7 8 2 
'" 
3 2 3 8 I 
Fauler , 4 2/ - ' 3 50 II 
b 2 2/ - ' 7 8 2 
Mother , 3 2 3 8 I 
d 4 3 , 62 2 
• Haplorype presumed ro encode disease gene(s) due to c:xpreuLon of HLA·A t. 
HLA-88 , HLA-DR3. HLA-DQw2. 
~ UndenllC'd allde. 
• Uncertainty whether the halplorypc: c:x'press~ thC' allele "X" or aD unddined allele. 
presenr against gliadin in 63% of antibody positive patients. bovine 
p-lactoglobulin in 82%. bovine gamma globulin in 9 1%. and bo-
vine casein in 45%. N o significant difference in the frequency of 
HLA·DQw2 or HLA-DR3 was noted when the an tibody negative 
and positive DH patients were compared. HLA-DPwl, however, 
was present in 9 of 11 (82%) of the IgA antibody positive DH 
patients as compared with only 4 of 12 (33%) of rhe IgA antibody 
negative DH patients. T his rrend did not reach statistical signin-
cance when corrected for the number of DP alle les tested for (Pc = 
0.25, corrected Fisher's exact test). 
DISCUSSION 
T hese dar.a extend the knowledge of the HLA phenotype of patienrs 
with DH to the DP region and confirm the strong associarion of 
DH wi rh the HLA class 1 antigens Al and B8 and the class n 
antigens DR3 and DQw2. We have found DPw1 more frequently 
in patients wi th DH. however. comparison of the frequency of 
DPwl in patients with DH and in DR3 and DQw2 normal subjects 
suggests that this association Inay be in pur or entirely due to the 
known posirive linkage disequilibrium of DPwl with DR3 and 
DQw2. 
Serum IgA antibod ies to a variety of dietary antigens were found 
more frequently in DH patients with DPwt than those without 
(relative risk = 9). however. th.is trend did not achieve statistical 
significance when corrected for the number of DP alleles analyzed. 
W e and others [25 - 27] have previously reported thar 30-50% of 
patients with DH have an IgA antibody response in the sera to a 
variety of dietary proteins and have IgA circulating immune com-
plexes. The finding of an increased frequencyofDPw1 in those DH 
patients who have IgA antibodies direcred against dietary antigens 
suggests that in D H the ability to generate such an 1 gA antibody 
response in the serum may be associated with the DPwl phenotype. 
Table v. HLA DPwl Antigen Frequency in DH Patients 
With and Without IgA Antibodies Against Dietary Antigens 
IgA antibody positive (n = 11) 
tgA antibody negative (n "'" 12) 
• Number of p;lticou. 
DPw l-Positive 
(n~ 13) 
9-
4 
DPwl.Negarive 
(n ~ 10) 
2 
8 
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Kagnoff 128] has reported that the abil ity of mice to generate an 
antibody response to the wheat protein A-gliadin is determined by 
the H~2 region of the murine MHC an.d the immunoglobulin heavy 
chain allotype locus. Funher investigation into the relationship of 
HLA-DP and the response to dietary ancigen in both DH patients 
and patients with ordinary GSE will be required to definitively 
determine if thc abiliry of patients with DH to develop an IgA 
an[ibody response to dietary antigens may be panially controlled by 
the HLA-DPwl gene. 
Our data also documents that DPw2 is negatively associated with 
OK. This negative association of DPw2 and DH cannot be attrib-
uted to negative linkage disequilibrium with DR3 or DQw2, or 
both. as DPw2 occurs more frequently in DR3 or DQw2 normal 
subjects. or both, than in the total population (Tables 11 and Ul). The 
family studies performed on patients with DH who express HLA-
DPw2 and their parents document that the HLA-DPw2 gene is not 
l?resent on 3 of3 of the haplotype presumed to contain the DH gene 
(i.e .. the haplotype encoding DR3 and DQw2). These data are 
consistcnt with the simple explanation that there is a single disease 
control gene that is in strong positive linkage disequilibrium with 
the DR3 and DQw2 alleles. but in strong negative linkage disequi-
librium with the DPw2 allele. Thus. this proposed "DH gene" 
would not occur with equal frequ ency on all DR3/ DQw2 hapla-
types but uther occur preferentially on those haplotypes that 
lack DPw2. 
An alternate. more complicated. explanation is that there are rwo 
independent "disease control genes" in the class II region. An aUde 
of one gene (DR3 or DQw2 or an allele of another gene in strong 
positive linkagc disequilibrium with those markers) increases the 
risk ofDH, whereas an allele of a second gene (DPw2 or an alleleof 
a gene in strong positive linkage disequilibrium with DPw2) de-
creases the risk of DH . Multigcne hypotheses are moS( consistent 
with the findings for DP and DR in juvenile rheumatoid anhritls 
[16J and have been proposed for a variety of other diseases, most 
notably diabetes mellitus [29J. 
Recently Howell and co-workers fl8} have reported that patients 
with ordinary GSE (celiac disease) have HLA-DP a and p chain 
RFLP that occur infrequently in normal HLA-DR3 or HLA-
DQw2 control subjects. T hey did not . however, report on the 
HLA-DP phenotypes of their patients with ordinary GSE r17,181. 
W c- predict. based on attempts to integrate their data with our own. 
that their RFLP may be strongly ~sociated with both DPwt and 
OPw3, both of which are elevated in frequency in our patient sam-
ple. Combined risk for DPwl and OPw3 considerc-djointly for our 
patient sample would be: 7.7. These alldes are similar to each other 
in that cellular reagents often show cross reaction berween these 
two products 113}. Perhaps OP molecules contribute part of the 
susceptibility to OH and disrinctivt: epitopes shared by DPwl and 
DPw3 constitute a critical region of interaction for some disease-
c.using peptide, as proposed by Todd et al [30J. 
In addition to an association of DH with HLA-DR3. Sachs et al 
18J have reported that HLA-DR2 was present mOfe frequently in 
patients with DH (57%) than normal controls (32%) or patients 
with ordinary GSE (12%). In contrast. we did nOt detect an in-
creased frequency of HLA-DR2 but rather found that only 16% of 
our patients with DH were HLA-DR2 positive. This decreased 
frequency of HLA-DR2 did not reach statistical significance when 
corrected for the number of alleles tested for. Analysis of DQw2 
positive: normal controls reveals a negative linkage disequilibrium 
of DQw2 and OR2 suggesting that the decreased frequency of DR2 
in patients with DH is not primarily associated with DH 13 1]. 
OUf data aho implicates the OQw2 antigen in the pathogenesis 
of DH as DQw2 was present in 100% of our patients with DH as 
compared with 40% of normal subjects. It is possible that DQw2 is 
the gene responsib le for DH and that the low prevalence of DH is 
due to variable penetrance. HLA-DQw2 positive individuals may 
require an exposure to as of yet unidentified environmental factors 
(viral infections, etc.) before the clinical manifestations of DH 
become apparent. Rccently~ biochemical evidence has been reported 
showing that there is heterogeneity of the serologically defined 
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HLA.OQw2 proteins r32]' It is possible that patients with DH have 
a unique DQw2 antigen that may result in the development ofDH. 
Alternatively. it is also possible that the serologicaHy determined 
DQw2 antigen is not the "DH gene" aud there may be a gene in 
linkage disequilibrium with DQw2 thar confers the susceptibility 
to DH. 
Dennatitis herperifonnis and a number of other diseases are 
known to be associated wirh certain HLA phenotypes, however. the 
role these associations play in the pathophysiology of humn au-
toimmune diseas(' is not known. Several distinct possibilities have 
been proposed to explain the role of HLA associations and disease. 
The HLA antigen may act as receptors for the specific antigen 
involved in the pathogenesis of the disease in question, may mimic 
the molecular structure of the inciting agent, or may be closely 
linked to a disease gene. The ability to clearly define the OH parienr 
population by direcr immunofluorescence analysis of skin biopsies, 
the observations that gliadin plays an important role in the develop-
ment of DH and the characterization of the HLA class JJ :;)ssocia-
tions with DH all make DH a useful model for the exploration 
of the role of HLA in disease. Characterization of the molecular 
structure of the HLA class II antigens in patients with DH and in 
patients with ordinary GSE may provide imponanr information in 
the pathogenesis of both DH and ordinary GSE. 
Wlr ,hank Dr. Y. Shimizu Jor II t/pful discussions and Ms. Dial/(l Appfrgalt jor 
'yping the manuscript. 
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